Stocks have support on better-than-expected stock earnings news. Apple is up more than +2% after forecasting a ...

Bernstein SocGen Group revised its price target for Regeneron (NASDAQ:REGN) Pharmaceuticals (NASDAQ: REGN) to $1,000 from the previous $1,070, while retaining an Outperform rating on the stock.

We recently published a list of 12 Undervalued Cyclical Stocks to Buy Right Now In this article, we are going to take a look ...

Goldman Sachs analyst Jerry Revich, maintaining a Buy rating and $442 price forecast, expressed views on Caterpillar, Inc.'s ...

IBM saw a remarkable 12% surge in its stock price on Thursday, driven by a strong fourth-quarter performance that showcased ...

Engineered Products is expected to grow low single digits organically, supported by aerospace and defense strength in the second half of 2025. Clean Energy & Fueling is projected to lead margin ...

The U.S. economy grew 2.3% in the fourth quarter as consumers again powered gains. Here's what the showing could mean for Fed ...

The bank on Thursday ditched its closely watched cost target for 2025, saying it wanted to make investments in business. It ...

Tata Motors shares react to Q3FY25 profit slump with mixed brokerage reviews. Explore target price insights from CLSA, GS, ...

We recently compiled a list of the Goldman Sachs’ 35 AI Superstars. In this article, we are going to take a look at where ...

Goldman Sachs reiterates Buy on Walmart with a $101 target, citing strong earnings growth, automation benefits, and upcoming ...

The U.S. economy slowed but continued to grow at a healthy rate in the fourth quarter, if forecasters are correct.